| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Andrew John Partridge | EVP & Chief Commercial Officer | $2.92 M | Feb 9, 2022 | ||
| Annette North | EVP & General Counsel | $2.13 M | Feb 9, 2022 | ||
| Siegfried Reich | EVP & Chief Scientific Officer | $1.29 M | Feb 9, 2022 | ||
| Mohammad Hirmand | EVP and Chief Medical Officer | Aug 17, 2022 | |||
| Paolo Tombesi | EVP & Chief Financial Officer | Aug 17, 2022 | |||
| Brian Sun | SVP & General Counsel | Aug 17, 2022 | |||
| Steve M. Sabus | SVP & Chief Commercial Officer | Aug 17, 2022 | |||
| Garry A. Nicholson | Director | Aug 17, 2022 | |||
| Kyri K. Van Hoose | Principal Accounting Officer | May 14, 2021 | |||
| Simeon George | Director | Aug 17, 2022 | |||
| Mark J. Alles | Director | Aug 17, 2022 | |||
| Patrick Machado | Director | Aug 17, 2022 | |||
| Athena Countouriotis | President & CEO, Director | Aug 17, 2022 | |||
| Carol Giltner Gallagher | Director | Aug 17, 2022 | |||
| Barbara W. Bodem | Director | Aug 17, 2022 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|